Literature DB >> 7615822

Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins.

S R Patel1, H Q Ke, R Vanholder, R J Koenig, C H Hsu.   

Abstract

The genomic action of calcitriol (1,25-dihydroxy-vitamin D3) is mediated through the interaction of the calcitriol receptor (VDR) with vitamin D response elements (VDREs). Although renal failure is associated with resistance to the action of calcitriol, the mechanism of this resistance is not well understood. Therefore, we used the electrophoretic mobility shift assay to compare the ability of VDRs from normal and renal failure rats to bind to the osteocalcin gene VDRE. The results indicate that VDRs from renal failure rats have only half the DNA binding capacity as VDRs from control rats, despite identical calcitriol binding. Furthermore, incubation of normal VDRs with a uremic plasma ultrafiltrate resulted in a loss of > 50% of the binding sites for the osteocalcin VDRE. When VDRs bound to DNA as heterodimers with retinoid X receptors, the inhibitory effect of the uremic ultrafiltrate was due to a specific interaction with the VDR, not retinoid X receptors. In addition, uremic ultrafiltrate blocked calcitriol-induced reporter gene activity in transfected JEG-3 cells. Taken together, the results indicate that an inhibitory effect of a uremic toxin(s) on VDR-VDRE binding could underlie the calcitriol resistance of renal failure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615822      PMCID: PMC185172          DOI: 10.1172/JCI118061

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Mechanism of decreased calcitriol degradation in renal failure.

Authors:  C H Hsu; S R Patel; E W Young
Journal:  Am J Physiol       Date:  1992-02

2.  Characterization of 1,25-dihydroxyvitamin D3 receptor interactions with target sequences in the rat osteocalcin gene.

Authors:  M B Demay; M S Kiernan; H F DeLuca; H M Kronenberg
Journal:  Mol Endocrinol       Date:  1992-04

3.  Subfractions in uremic plasma ultrafiltrate inhibit calcitriol metabolism.

Authors:  C H Hsu; R Vanholder; S Patel; R R De Smet; P Sandra; S M Ringoir
Journal:  Kidney Int       Date:  1991-11       Impact factor: 10.612

4.  No decrease of 1,25(OH)2D3 receptors and duodenal calbindin-D9k in uraemic rats.

Authors:  A Szabo; J Merke; M Thomasset; E Ritz
Journal:  Eur J Clin Invest       Date:  1991-10       Impact factor: 4.686

5.  Vitamin D receptor interaction with specific DNA. Association as a 1,25-dihydroxyvitamin D3-modulated heterodimer.

Authors:  T Sone; S Kerner; J W Pike
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

6.  Regulation of parathyroid hormone synthesis in chronic renal failure in rats.

Authors:  M Fukagawa; S Kaname; T Igarashi; E Ogata; K Kurokawa
Journal:  Kidney Int       Date:  1991-05       Impact factor: 10.612

7.  Vitamin D receptor interaction with specific DNA requires a nuclear protein and 1,25-dihydroxyvitamin D3.

Authors:  J Liao; K Ozono; T Sone; D P McDonnell; J W Pike
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

8.  A nuclear protein essential for binding of rat 1,25-dihydroxyvitamin D3 receptor to its response elements.

Authors:  T K Ross; V E Moss; J M Prahl; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

9.  DNA binding specificity and function of retinoid X receptor alpha.

Authors:  J S Subauste; R W Katz; R J Koenig
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

10.  Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling.

Authors:  S A Kliewer; K Umesono; D J Mangelsdorf; R M Evans
Journal:  Nature       Date:  1992-01-30       Impact factor: 49.962

View more
  17 in total

Review 1.  Renal osteodystrophy.

Authors:  E A González; K J Martin
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

2.  Ethnic differences in 25-hydroxyvitamin D levels and response to treatment in CKD.

Authors:  Iris Sanchez; Roberto Mangoo-Karim; Jason R Stubbs; George P Yanev; James B Wetmore
Journal:  Int Urol Nephrol       Date:  2012-05-30       Impact factor: 2.370

Review 3.  Vitamin D and its analogs in chronic renal failure.

Authors:  E Slatopolsky; A J Brown
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Vitamin D and chronic kidney disease-mineral bone disease (CKD-MBD).

Authors:  Sagar U Nigwekar; Hector Tamez; Ravi I Thadhani
Journal:  Bonekey Rep       Date:  2014-02-05

Review 5.  Regulation of parathyroid function in chronic renal failure.

Authors:  Mariano Rodriguez; Sagrario Cañadillas; Ignacio Lopez; Escolástico Aguilera-Tejero; Yolanda Almaden
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

Review 6.  Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies.

Authors:  Mariano Rodríguez Portillo; María E Rodríguez-Ortiz
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

7.  Thyroid hormone receptor binding to DNA and T3-dependent transcriptional activation are inhibited by uremic toxins.

Authors:  Guilherme M Santos; Carlos J Pantoja; Aluízio Costa E Silva; Maria C Rodrigues; Ralff C Ribeiro; Luiz A Simeoni; Noureddine Lomri; Francisco Ar Neves
Journal:  Nucl Recept       Date:  2005-04-04

8.  Vitamin D prevents hypoxia/reoxygenation-induced blood-brain barrier disruption via vitamin D receptor-mediated NF-kB signaling pathways.

Authors:  Soonmi Won; Iqbal Sayeed; Bethany L Peterson; Bushra Wali; Jared S Kahn; Donald G Stein
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

Review 9.  Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease.

Authors:  Joao F de Brito Galvao; Larry A Nagode; Patricia A Schenck; Dennis J Chew
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2013 Mar-Apr

10.  The vitamin d receptor and T cell function.

Authors:  Martin Kongsbak; Trine B Levring; Carsten Geisler; Marina Rode von Essen
Journal:  Front Immunol       Date:  2013-06-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.